Urteste S.A. (URT.WA)
PLN 92.8
(-1.28%)
PLN 92.8
(-1.28%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 29.59 Million PLN | 342.16% |
| 2022 | 6.69 Million PLN | -32.66% |
| 2021 | 9.93 Million PLN | 618.59% |
| 2020 | 1.38 Million PLN | 11.62% |
| 2019 | 1.23 Million PLN | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 28.21 Million PLN | -4.66% |
| 2024 Q2 | 28.5 Million PLN | 1.03% |
| 2023 Q1 | 5.21 Million PLN | -22.05% |
| 2023 Q4 | 29.59 Million PLN | -2.47% |
| 2023 Q3 | 30.34 Million PLN | -3.24% |
| 2023 Q2 | 31.36 Million PLN | 501.09% |
| 2023 FY | 29.59 Million PLN | 342.16% |
| 2022 Q1 | 8.88 Million PLN | -10.62% |
| 2022 Q4 | 6.69 Million PLN | -12.45% |
| 2022 Q3 | 7.64 Million PLN | -10.74% |
| 2022 Q2 | 8.56 Million PLN | -3.58% |
| 2022 FY | 6.69 Million PLN | -32.66% |
| 2021 Q1 | 734.99 Thousand PLN | 0.0% |
| 2021 FY | 9.93 Million PLN | 618.59% |
| 2021 Q4 | 9.93 Million PLN | -5.74% |
| 2021 Q3 | 10.54 Million PLN | 219.71% |
| 2021 Q2 | 3.29 Million PLN | 348.77% |
| 2020 FY | 1.38 Million PLN | 11.62% |
| 2019 FY | 1.23 Million PLN | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Bioceltix S.A. | 12.73 Million PLN | -132.409% |
| BIOTON S.A. | 822.22 Million PLN | 96.4% |
| Captor Therapeutics Spolka Akcyjna | 97.29 Million PLN | 69.579% |
| Mabion S.A. | 208.25 Million PLN | 85.788% |
| Molecure S.A. | 168.57 Million PLN | 82.442% |
| NanoGroup S.A. | 8.63 Million PLN | -242.903% |
| Pharmena S.A. | 24.13 Million PLN | -22.65% |
| Poltreg S.A. | 127.09 Million PLN | 76.712% |
| Pure Biologics Spólka Akcyjna | 22.73 Million PLN | -30.17% |
| Ryvu Therapeutics S.A. | 403.2 Million PLN | 92.659% |
| Synthaverse S.A. | 265.9 Million PLN | 88.869% |